Eligen B12™
Eligen B12™ is a once-daily oral non-prescription medical food, which normalises B12 levels without injection.
Tolero Pharmaceuticals doses first patient in Phase II Zella 202 study
Myeloblasts with Auer rods seen in Acute Myeloid Leukemia (AML), advanced stage. Credit: Paulo Henrique Orlandi Mourao.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry
-
SWIL Systems
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video...
About
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video conference solutions for clinical researchers, including contract research organisations (CROs), sponsors and institutions.
FollowMake an Enquiry